Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001162194-23-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | LAB | Davis Jeremy Steven | SVP Chief Commercial Off | M - OptEx | $0.00 | +20.8K | 20.8K | New | $0 |
| D | 2023-02-23 | 2023-02-21 | LAB | Davis Jeremy Steven | SVP Chief Commercial Off | F - Tax | $2.03 | -6,176 | 14.7K | -30% | -$12.5K |
| D | 2023-02-23 | 2023-02-21 | LAB | Davis Jeremy Steven | SVP Chief Commercial Off | M - OptEx | $0.00 | -20.8K | 229.2K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | M | A | 20,833 | $0.00 | 20,833 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-21 | F | D | 6,176 | $2.03 | 14,657 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-21 | M | D | 20,833 | $0.00 | 229,167 | D | — · — to — | 20,833 Common Stock | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. (F2) On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023. |